CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
given with chemotherapy to adults with extensive-stage small cell lung cancer (ES-SCLC), a fast-growing type of lung cancer...
Phase 2, Phase 3
New Braunfels, Texas, United States and 31 other locations
combination) vs durvalumab in limited-stage (LS)-small-cell lung cancer (SCLC) participants.The main goals of this study are to:* E...
Phase 2
Austin, Texas, United States and 32 other locations
The goal of this platform clinical trial is to test how well novel treatment combinations work in participants with lung cancer. Su ...
Phase 2
Austin, Texas, United States and 99 other locations
This clinical trial is studying nonsquamous non-small cell lung cancer (NSCLC). Participants in this study must have cancer...
Phase 3
Austin, Texas, United States and 342 other locations
This is a Phase III, randomized, double-blind, placebo-controlled, multi-center international study assessing the activity of durvalumab and chemothe...
Phase 3
Austin, Texas, United States and 230 other locations
The purpose of ARTEMIDE-Lung02 is to assess the efficacy and safety of rilvegostomig in combination with platinum-based chemotherapy for the ...
Phase 3
Round Rock, Texas, United States and 300 other locations
(pembrolizumab with chemotherapy) for adults with a type of lung cancer called non-small cell lung cancer (NSCLC)...
Phase 3
Austin, Texas, United States and 227 other locations
Non-small cell lung cancer (NSCLC) is a common type of lung cancer where abnormal cells in the lungs gro...
Phase 2, Phase 3
Austin, Texas, United States and 46 other locations
this study is to evaluate the efficacy and safety of ZL-1310 compared to Investigator's Choice Therapy in participants with relapsed Small Cell Lung...
Phase 3
Austin, Texas, United States and 33 other locations
This is a Phase II, Open Label, Multicenter, Single Arm Study of WSD0922-FU for Patients with Locally Advanced or Metastatic Non-Small Cell Lung...
Phase 2
Austin, Texas, United States and 17 other locations
Clinical trials
Research sites
Resources
Legal